Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

21.45HKD
23 Jul 2018
Change (% chg)

HK$-0.85 (-3.81%)
Prev Close
HK$22.30
Open
HK$22.00
Day's High
HK$22.20
Day's Low
HK$20.85
Volume
50,616,267
Avg. Vol
36,709,101
52-wk High
HK$26.75
52-wk Low
HK$11.82

Latest Key Developments (Source: Significant Developments)

Cspc Pharmaceutical Group Says Captopril Tablets Granted Approval
Tuesday, 10 Jul 2018 

July 10 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CAPTOPRIL TABLETS GRANTED APPROVAL BY CHINA DRUG ADMINISTRATION.CAPTOPRIL TABLETS GRANTED APPROVAL FOR PASSING CONSISTENCY OF QUALITY AND EFFICACY EVALUATION OF GENERIC DRUGS.  Full Article

CSPC Pharmaceutical Says U.S. FDA Approved Investigational New Drug Application For "CSPCHA115"
Tuesday, 10 Jul 2018 

July 10 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::U.S. FOOD AND DRUG ADMINISTRATION APPROVED INVESTIGATIONAL NEW DRUG APPLICATION FOR "CSPCHA115".  Full Article

CSPC Pharmaceutical Group Says Qimaite Drug Granted Approval By China Food And Drug Administration
Monday, 21 May 2018 

May 21 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::GROUP'S "QIMAITE" GRANTED APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION.  Full Article

CSPC Pharmaceutical Group Updates On Clinical Trial Approval For Injection By China FDA
Thursday, 10 May 2018 

May 10 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::"Q101-PEGYLATED RECOMBINANT HUMAN INTERFERON-2A FOR INJECTION" GRANTED CLINICAL TRIAL APPROVAL BY CHINA FDA.  Full Article

CSPC Pharmaceutical Group Updates on Drug Registration Approval For Injection By China FDA
Thursday, 10 May 2018 

May 10 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC PHARMACEUTICAL GROUP-"DOXOFYLLINE GLUCOSE FOR INJECTION" GRANTED DRUG REGISTRATION APPROVAL BY CHINA FDA."DOXOFYLLINE SODIUM CHLORIDE FOR INJECTION" GRANTED DRUG REGISTRATION APPROVAL BY CHINA FDA.  Full Article

CSPC Pharmaceutical Group Says Cancer Drug Approved By China FDA
Monday, 16 Apr 2018 

April 16 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::"VINORELBINE TARTRATE LIPOSOME INJECTION" GRANTED CLINICAL TRIAL APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION OF PRC.  Full Article

CSPC Pharmaceutical Group's Drug Gets Approval By China FDA
Thursday, 12 Apr 2018 

April 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::GRANTED APPROVAL BY CHINA FDA FOR PASSING CONSISTENCY OF QUALITY AND EFFICACY EVALUATION OF GENERIC DRUGS.APPROVAL FOR GROUP'S DRUG "WEIHONG".  Full Article

CSPC Pharmaceutical Group Announces Drug Registration Approval Of "Paclitaxel For Injection (Albumin-Bound)"
Monday, 12 Feb 2018 

Feb 12 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::‍"PACLITAXEL FOR INJECTION (ALBUMIN-BOUND)" GRANTED DRUG REGISTRATION APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION.  Full Article

CSPC Pharmaceutical Group Announces Acquisition Of Stake In Wuhan Yzy Biopharma Co
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - CSPC Pharmaceutical Group <1093.HK>::ACQUISITION OF 39.56% EQUITY INTEREST IN WUHAN YZY BIOPHARMA CO., LTD.DEAL FOR UP TO RMB356 MILLION.  Full Article

CSPC Pharmaceutical Group Says Unit's Listing Application To CSRC Was Accepted
Wednesday, 27 Dec 2017 

Dec 27 (Reuters) - CSPC Pharmaceutical Group Ltd <1093.HK>::CSPC XNW SUBMITTED APPLICATION TO CSRC FOR PROPOSED A SHARE LISTING ON CHINEXT OF SZSE & RECEIVED NOTICE OF ACCEPTANCE.‍EXPECTED THAT CSPC XNW WILL REMAIN AS AN INDIRECT SUBSIDIARY OF CO.  Full Article

HK stocks edge higher on financials as Beijing injects liquidity

* Hang Seng up 0.1 pct; HSCE rises 0.5 pct HSI financial sector sub-index 0.6 pct higher; property sector up 0.7 pct